APA (7th ed.) Citation

PB, W., M, C., PL, P., & H, O. (2022). Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma. Current opinion in oncology, 34(6), 661. https://doi.org/10.1097/CCO.0000000000000877

Chicago Style (17th ed.) Citation

PB, Watchmaker, Colton M, Pineo-Cavanaugh PL, and Okada H. "Future Development of Chimeric Antigen Receptor T Cell Therapies for Patients Suffering from Malignant Glioma." Current Opinion in Oncology 34, no. 6 (2022): 661. https://doi.org/10.1097/CCO.0000000000000877.

MLA (9th ed.) Citation

PB, Watchmaker, et al. "Future Development of Chimeric Antigen Receptor T Cell Therapies for Patients Suffering from Malignant Glioma." Current Opinion in Oncology, vol. 34, no. 6, 2022, p. 661, https://doi.org/10.1097/CCO.0000000000000877.